financetom
Business
financetom
/
Business
/
Stellantis to Phase Out PHEVs in North America
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Stellantis to Phase Out PHEVs in North America
Mar 11, 2026 12:15 AM

04:49 PM EST, 01/09/2026 (MT Newswires) -- Stellantis ( STLA ) plans to phase out its plug-in hybrid vehicles in North America beginning 2026, and focus on hybrid and range extended vehicles, the company told MT Newswires.

"Stellantis ( STLA ) will phase out plug in hybrid (PHEV) programs in North America beginning with the 2026 model year, and focus on more competitive electrified solutions, including hybrid and range extended vehicles," company confirmed.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
EU presses ahead with Chinese EV tariffs after split vote
EU presses ahead with Chinese EV tariffs after split vote
Oct 4, 2024
* Commission says it has necessary support for tariffs * Says will continue talks with Beijing * More states back tariffs than oppose, many abstentions * Case is Commission's biggest trade clash with China in a decade * Beijing has threatened retaliation if tariffs go ahead By Philip Blenkinsop BRUSSELS, Oct 4 (Reuters) - Brussels will stick to plans to...
Market Chatter: Archer-Daniels-Midland to Idle Iowa Soybean Plant
Market Chatter: Archer-Daniels-Midland to Idle Iowa Soybean Plant
Oct 4, 2024
08:14 AM EDT, 10/04/2024 (MT Newswires) -- Archer-Daniels-Midland ( ADM ) is idling its sole soybean processing facility in Iowa during the peak of the US harvest, Reuters reported Friday, citing the company. The temporary closure limits a key market for farmers as low crop prices hit incomes and pushes soymeal prices at the Gulf terminal to their highest in...
Sage Therapeutics Faces High-Risk Outlook Amid Concerns Over Success in Phase 2 Huntington's Disease Trial, RBC Says
Sage Therapeutics Faces High-Risk Outlook Amid Concerns Over Success in Phase 2 Huntington's Disease Trial, RBC Says
Oct 4, 2024
07:46 AM EDT, 10/04/2024 (MT Newswires) -- Sage Therapeutics ( SAGE ) faces a high-risk outlook as it awaits the year-end phase 2 readout for its Huntington's disease treatment, dalzanemdor, RBC Capital Markets said in a report Friday. RBC's analysis suggests dalzanemdor is unlikely to show clear, clinically meaningful effects in Huntington's or Alzheimer's. Without success, long-term profitability will be...
Update: Ford SUVs Under Probe for Loss of Braking; Nearly 370,000 Vehicles Affected
Update: Ford SUVs Under Probe for Loss of Braking; Nearly 370,000 Vehicles Affected
Oct 4, 2024
08:14 AM EDT, 10/04/2024 (MT Newswires) -- (Updates to add statement from Ford in the third paragraph.) Ford Motor's ( F ) Edge crossover SUVs from model years 2015-2017 are being investigated for complaints alleging loss of braking due to rear brake hose failure, the National Highway Traffic Safety Administration said Thursday. A total of 368,309 crossovers in the US...
Copyright 2023-2026 - www.financetom.com All Rights Reserved